FDA Announces Glucagon-Injecting Device Recall
The FDA has announced today that Novo Nordisk has made the decision torecall six batches of the glucagon-injecting devices after it has been reported that needles in the GlucaGen HypoKit have detached from the syringes. A detachment of the needle was reported to Novo Nordisk by a customer in Portugal and one from the…